comparemela.com

Latest Breaking News On - Timothy eley - Page 1 : comparemela.com

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001.

United statesKatie andersonRam bhamidimarriRonaldg nahassDeana antonielloKosh agarwalAnita kohliJeong heoGavin clohertyLouise busseyNaim alkhouriShariec ganchuaStuartc gordonChristinel espirituTatiana burdaStuart roberts

Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023

Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its.

United statesMark andersonGavin clohertySam galhenageMarie louise vachonMagdy elkhashabKrasimir antonovArpita mondalChao wei hsuVarun sharmaCalvin chanScott davisonKaren simsRobert baileyStuartk robertsChristine espiritu

Arbutus Announces Three Poster Presentations with Clinical Data from AB-729 and Preclinical Data from AB-101 at AASLD - The Liver Meeting® 2022

Conference Call and Webcast to discuss the new data being presented at AASLD scheduled for 8:45 AM ET, Friday, November 4, 2022

United statesJacob georgeMariana radichevaCalvin chanMagdy elkhashabTimothy eleyApinya leerapunSimonei strasserWilliamh collierDiana stefanova petrovaKrasimir antonovStevenj knoxMarie louise vachonMichele andersonSeyma ozturkPisit tangkijvanich

vimarsana © 2020. All Rights Reserved.